JESSICA SPINELLI: Open Payments
NPI 1205511417 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,638 in 154 payments from 15 companies in 2025. Trend: 2023 $206 · 2024 $1,374 · 2025 $2,638
Food & beverage: $2,638
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 32 | $432 |
| Incyte Corporation | 23 | $409 |
| ABBVIE INC. | 25 | $327 |
| Arcutis Biotherapeutics, Inc. | 9 | $241 |
| Lilly USA, LLC | 16 | $236 |
| Novartis Pharmaceuticals Corporation | 9 | $215 |
| Amgen Inc. | 7 | $186 |
| Organon LLC | 12 | $185 |
| Journey Medical Corporation | 4 | $154 |
| Regeneron Healthcare Solutions, Inc. | 9 | $139 |
Products named: OPZELURA, AKLIEF, Zoryve, Otezla, NEMLUVIO, SKYRIZI, RINVOQ, TALTZ.
Industry payments across NJ — which companies pay providers there.
